Everyone knows that people living with overweight /obesity are at a higher risk for a multitude of chronic conditions such as type 2 diabetes, coronary heart disease, stroke, certain cancers (endometrial, breast, ovarian, prostate, liver, gallbladder, kidney and colon), digestive problems, sleep apnea, respiratory problems, osteoarthritis, fatty liver disease, and severe COVID-19 symptoms. It therefore stands to reason, that by prioritizing weight management support, and prevention of weight gain, pharmacists could be significantly improving health outcomes for people affected by excess adiposity. So WHY AREN’T WE DOING THIS?!

Let’s talk “About That Bass” and let’s be “Ready For” the next person living with obesity who comes into our pharmacy so that we will be better able to support their health goals.

Sponsored by: Novo Nordisk